Sphingoid bases and their phosphates: Transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity

Toxicology

Volumn 187, Issue 2-3, 2003, Pages 239-250

  Gopee, Neera V ^a   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Fumonisin B1; Myriocin; Protein kinase C; Sphinganine; Sphinganine 1 phosphate; Sphingolipids

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; FUMONISIN B1; ISOENZYME; N,N DIMETHYLSPHINGOSINE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ZETA; SPHINGANINE; SPHINGANINE 1 PHOSPHATE; SPHINGANINE KINASE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; THERMOZYMOCIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME REPRESSION; EPITHELIUM CELL; KIDNEY EPITHELIUM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; SWINE;

SPHINGIODEA; SUIDAE;

EID: 0037417439     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00048-9     Document Type: Article

References (48)

1. Bamberger A.M., Bamberger C.M., Wald M., Kratzmeier M., Schulte H.M. Protein kinase C (PKC) isoenzyme expression pattern as an indicator of proliferative activity in uterine tumor cells. Mol. Cell Endocrinol. 123:1996;81-88.
2. Banno Y., Fujita H., Ono Y., Nakashima S., Ito Y., Kuzumaki N., Nozawa Y. Differential phospholipase D activation by bradykinin and sphingosine 1-phosphate in NIH 3T3 fibroblasts overexpressing gelsolin. J. Biol. Chem. 274:1999;27385-27391.
3. Bourbon N.A., Yun J., Berkey D., Wang Y., Kester M. Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am. J. Physiol. Cell Physiol. 280:2001;C1403-C1411.
4. Chmura S.J., Nodzenski E., Weichselbaum R.R., Quintans J. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56:1996;2711-2714.
5. Clarke H., Ginanni N., Soler A.P., Mullin J.M. Regulation of protein kinase C-δ and -ε isoforms by phorbol ester treatment of LLC-PK1 renal epithelia. Kidney Int. 58:2000;1004-1015.
6. Davaille J., Li L., Mallat A., Lotersztajn S. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J. Biol. Chem. 277:2002;37323-37330.
7. Edsall L.C., Van Brocklyn J.R., Cuvillier O., Kleuser B., Spiegel S. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry. 37:1998;12892-12898.
8. Gennero I., Fauvel J., Nieto M., Cariven C., Gaits F., Briand-Mesange F., Chap H., Salles J.P. Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. J. Biol. Chem. 277:2002;12724-12734.
9. Gopee N.V., Sharma R.P. Fumonisin B1 induces translocation of protein kinase C-α in cultured renal LLC-PK1 cells. Toxicol. Sci. 66:(Suppl. 1S):2002;7.
10. Hannun Y.A., Loomis C.R., Merrill A.H. Jr., Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261:1986;12604-12609.
11. Hannun Y.A., Bell R.M. Regulation of protein kinase C by sphingosine and lysosphingolipids. Clin. Chim. Acta. 185:1989;333-345.
12. Hannun Y.A., Linardic C.M. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim. Biophys. Acta. 1154:1993;223-236.
13. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
14. Hauser J.M., Buehrer B.M., Bell R.M. Role of ceramide in mitogenesis induced by exogenous sphingoid bases. J. Biol. Chem. 269:1994;6803-6809.
15. He Q., Riley R.T., Sharma R.P. Fumonisin-induced tumor necrosis factor-α expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. Toxicol. Appl. Pharmacol. 174:2001;69-77.
16. Howard P.C., Eppley R.M., Stack M.E., Warbritton A., Voss K.A., Lorentzen R.J., Kovach R.M., Bucci T.J. Fumonisin B1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109:(Suppl. 2):2001;277-282.
17. Hsu S.C., Wu C.C., Luh T.Y., Chou C.K., Han S.H., Lai M.Z. Apoptotic signal of Fas is not mediated by ceramide. Blood. 91:1998;2658-2663.
18. Hull R.N., Cherry W.R., Weaver G.W. The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro. 12:1976;670-677.
19. Kontny E., Ziolkowska M., Ryzewska A., Maslinski W. Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Cytokine. 11:1999;839-848.
20. La Porta C.A., Tessitore L., Comolli R. Changes in protein kinase C α, δ and in nuclear β isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat. Carcinogenesis. 18:1997;715-719.
21. La Porta C.A., Comolli R. PKC-dependent modulation of IκB-NFκB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res. 18:1998;2591-2597.
22. Lampasso J.D., Kamer A., Margarone J. III, Dziak R. Sphingosine-1-phosphate effects on PKC isoform expression in human osteoblastic cells. Prostaglandins Leukot. Essent. Fatty Acids. 65:2001;139-146.
23. Limatola C., Barabino B., Nista A., Santoni A. Interleukin 1-β-induced protein kinase C-ζ activation is mimicked by exogenous phospholipase D. Biochem. J. 321:1997;497-501. Part 2.
24. Linn S.C., Kim H.S., Keane E.M., Andras L.M., Wang E., Merrill A.H. Jr. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 29:2001;831-835.
25. Lozano J., Berra E., Municio M.M., Diaz-Meco M.T., Dominguez I., Sanz L., Moscat J. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269:1994;19200-19202.
26. Merrill A.H. Jr., Sereni A.M., Stevens V.L., Hannun Y.A., Bell R.M., Kinkade J.M. Jr. Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases. J. Biol. Chem. 261:1986;12610-12615.
27. Merrill A.H. Jr., van Echten G., Wang E., Sandhoff K. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268:1993;27299-27306.
28. Merrill A.H. Jr., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., Wang E. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142:1997;208-225.
29. Reyland M.E., Anderson S.M., Matassa A.A., Barzen K.A., Quissell D.O. Protein kinase C δ is essential for etoposide-induced apoptosis in salivary gland acinar cells. J. Biol. Chem. 274:1999;19115-19123.
30. Rheeder J.P., Marasas W.F.O., Thiel P.G., Sydenham E.W., Shephard G.S., Van Schalwyck D.J. Fusarium moniliforme and fumonisin in corn in relation to human esophageal cancer in Transkei. Phytopathology. 357:1992;353.
31. Riboni L., Viani P., Bassi R., Prinetti A., Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:1997;153-195.
32. Riley R.T., Voss K.A., Norred W.P., Sharma R.P., Wang E., Merrill A.H. Fumonisins: mechanism of mycotoxicity. Rev. Med. Vet. 149:1998;617-626.
33. Riley R.T., Norred W.P., Wang E., Merrill A.H. Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices. Nat. Toxins. 7:1999;407-414.
34. Riley R.T., Enongene E., Voss K.A., Norred W.P., Meredith F.I., Sharma R.P., Spitsbergen J., Williams D.E., Carlson D.B., Merrill A.H. Jr. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109:(Suppl. 2):2001;301-308.
35. Sadahira Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc. Natl. Acad. Sci. USA. 89:1992;9686-9690.
36. Scaglione-Sewell B., Abraham C., Bissonnette M., Skarosi S.F., Hart J., Davidson N.O., Wali R.K., Davis B.H., Sitrin M., Brasitus T.A. Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res. 58:1998;1074-1081.
37. Sharma R.P., Bhandari N., He Q., Riley R.T., Voss K.A. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. Toxicology. 159:2001;69-79.
38. Skrzypek M.S., Nagiec M.M., Lester R.L., Dickson R.C. Analysis of phosphorylated sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. J. Bacteriol. 181:1999;1134-1140.
39. Smith E.R., Jones P.L., Boss J.M., Merrill A.H. Jr. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J. Biol. Chem. 272:1997;5640-5646.
40. Spiegel S. Sphingosine and sphingosine 1-phosphate in cellular proliferation: relationship with protein kinase C and phosphatidic acid. J. Lipid Mediat. 8:1993;169-175.
41. Spiegel S., Milstien S. Sphingolipid metabolites: members of a new class of lipid second messengers. J. Membr. Biol. 146:1995;225-237.
42. Suga K., Sugimoto I., Ito H., Hashimoto E. Down-regulation of protein kinase C-α detected in human colorectal cancer. Biochem. Mol. Biol. Int. 44:1998;523-528.
43. Tepper A.D., Cock J.G., de Vries E., Borst J., van Blitterswijk W.J. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J. Biol. Chem. 272:1997;24308-24312.
44. Wang E., Norred W.P., Bacon C.W., Riley R.T., Merrill A.H. Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266:1991;14486-14490.
45. Yin J.J., Smith M.J., Eppley R.M., Troy A.L., Page S.W., Sphon J.A. Effects of fumonisin B1 and (hydrolyzed) fumonisin backbone AP1 on membranes: a spin-label study. Arch. Biochem. Biophys. 335:1996;13-22.
46. Yoo H.S., Norred W.P., Wang E., Merrill A.H. Jr., Riley R.T. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol. Appl. Pharmacol. 114:1992;9-15.
47. Yoo H.S., Norred W.P., Showker J., Riley R.T. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol. Appl. Pharmacol. 138:1996;211-218.
48. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114:1991;155-167.